Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis
- PMID: 33506961
- DOI: 10.1111/acps.13277
Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis
Abstract
Objective: The risk of relapse following successful antidepressant treatment, including electroconvulsive therapy (ECT), is substantial. Lithium has been suggested to effectively prevent relapse, yet data remain limited and inconclusive. We performed a systematic review and meta-analysis to examine the efficacy of continuation treatment with lithium in preventing relapse following a successful acute course of ECT in patients with major depression, in comparison to continuation treatment without lithium. We also assessed the role of several study characteristics, possibly impacting the treatment effect.
Methods: A systematic literature search, using the PubMed, Embase, Web of Science, and Cochrane Library databases (up to June 2020), was conducted for prospective and retrospective studies, including patients with unipolar or bipolar depression, that assessed the efficacy of lithium for post-ECT depressive relapse prevention.
Results: Of 2556 records screened, 14 articles reporting on 9748 participants who received continuation treatment either with (N = 1571) or without lithium (N = 8177) were included in the meta-analysis. Patients receiving lithium were less likely to experience depressive relapse after a successful acute course of ECT, compared to patients receiving post-ECT prophylaxis without lithium (weighted odds ratio (OR) = 0.53, 95% confidence interval (CI) = 0.34, 0.82), with a number needed to treat (NNT) of 7 (95% CI = 4, 21). We found some limited evidence that older patients may benefit more from continuation treatment with lithium, compared to younger patients. Using the GRADE criteria, the quality of evidence for our outcome measure (i.e., relapse rate) was rated as very low.
Conclusion: Continuation treatment with lithium may have superior efficacy in reducing the risk of relapse after a successful acute ECT course for major depression, in comparison to continuation treatment without lithium. High-quality studies are needed to confirm this finding.
Keywords: continuation treatment; depressive disorder; electroconvulsive therapy; lithium; relapse.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5. Cochrane Database Syst Rev. 2021. PMID: 34817851 Free PMC article.
-
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.Cochrane Database Syst Rev. 2021 Sep 12;9(9):CD011612. doi: 10.1002/14651858.CD011612.pub3. Cochrane Database Syst Rev. 2021. PMID: 34510411 Free PMC article.
-
Lithium for maintenance treatment of mood disorders.Cochrane Database Syst Rev. 2001;(3):CD003013. doi: 10.1002/14651858.CD003013. Cochrane Database Syst Rev. 2001. PMID: 11687035
-
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.Cochrane Database Syst Rev. 2022 Nov 24;11(11):CD014384. doi: 10.1002/14651858.CD014384.pub2. Cochrane Database Syst Rev. 2022. PMID: 36420692 Free PMC article.
-
Lithium for maintenance treatment of mood disorders.Cochrane Database Syst Rev. 2001;2001(2):CD003013. doi: 10.1002/14651858.CD003013. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2001;(3):CD003013. doi: 10.1002/14651858.CD003013. PMID: 11406061 Free PMC article. Updated.
Cited by
-
Clinical and sociodemographic characteristics associated with relapse following electroconvulsive therapy for bipolar disorder.Bipolar Disord. 2024 Dec;26(8):785-792. doi: 10.1111/bdi.13485. Epub 2024 Aug 12. Bipolar Disord. 2024. PMID: 39135138 Free PMC article.
-
Lithium bidirectionally regulates depression- and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder.Front Psychiatry. 2022 Sep 15;13:963005. doi: 10.3389/fpsyt.2022.963005. eCollection 2022. Front Psychiatry. 2022. PMID: 36186884 Free PMC article.
-
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.Transl Psychiatry. 2022 Sep 2;12(1):359. doi: 10.1038/s41398-022-02087-6. Transl Psychiatry. 2022. PMID: 36055984 Free PMC article.
-
Electroconvulsive Therapy-Induced Mania in Bipolar Disorder: A Case Report.Cureus. 2024 Dec 7;16(12):e75255. doi: 10.7759/cureus.75255. eCollection 2024 Dec. Cureus. 2024. PMID: 39764330 Free PMC article.
-
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.Pharmacol Rev. 2024 May 2;76(3):323-357. doi: 10.1124/pharmrev.120.000007. Pharmacol Rev. 2024. PMID: 38697859 Free PMC article. Review.
References
REFERENCES
-
- Otte C, Gold SM, Penninx BW, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065.
-
- Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917.
-
- Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand. 2020;141(4):304-315.
-
- Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38(12):2467-2474.
-
- Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217-222.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources